FAQ

IP Litigation North America is a leading annual conference bringing together senior in-house IP leaders, litigators, and legal decision-makers from across the United States and beyond. Designed for professionals navigating high-stakes patent and trade secret disputes, the event addresses the most pressing challenges shaping IP enforcement and defence in today’s innovation-driven economy.

Held in Boston, the conference focuses on cutting-edge issues across Pharma & Biotech, Technology & Innovation, and Trade Secrets, delivering practical, real-world insights into litigation strategy, forum selection, damages, injunctions, and regulatory overlap. The agenda features senior in-house counsel, experienced trial lawyers, and subject-matter experts, alongside interactive panels and peer-to-peer discussions, reflecting the increasingly complex, cross-border nature of IP disputes in North America and globally.

The event attracts delegates from Pharma & Biotech, Technology & Innovation, Medical Devices, Automotive & Mobility, Consumer Tech, Telecommunications, and Manufacturing, alongside leading patent litigation law firms and specialist service providers.

Yes. A significant portion of the agenda is shaped by in-house speakers and real-world case studies, ensuring discussions remain practical, strategic, and commercially grounded rather than purely academic.

Yes. While the focus is on North America, the agenda reflects the global and cross-border nature of IP litigation, making it highly relevant for international companies and counsel managing disputes across multiple jurisdictions.

Sessions are highly practical, focusing on real cases, recent developments, and actionable takeaways that attendees can apply directly to current or upcoming litigation matters.

IP Litigation North America is designed for senior professionals involved in patent and trade secret disputes, including in-house IP counsel, litigators, and legal decision-makers from life sciences, technology, and innovation-driven industries. The conference is particularly relevant for those responsible for litigation strategy, enforcement decisions, and managing external counsel.

Eligibility for complimentary is assessed on a case-by-case basis and is typically limited to qualified in-house professionals. All registrations are subject to approval to ensure audience quality and balance.

Absolutely. The conference is designed to maximise meaningful networking through structured networking breaks, informal discussions, and peer-to-peer conversations with senior in-house counsel, litigators, and industry experts.

Topics include patent enforcement and defence strategies, preliminary injunctions, damages and remedies, forum selection, trade secret litigation, SEP and FRAND disputes, regulatory overlap, and emerging trends impacting IP litigation in North America and globally.

IP Litigation North America is distinguished by its deep focus on litigation strategy, its strong in-house representation, and its industry-specific tracks, enabling more targeted and relevant discussions than broader IP or legal conferences.